The association of hypertension and diabetes pharmacotherapy with COVID-19 severity and immune signatures: an observational study
Rinkoo DalanDepartment of Endocrinology, Tan Tock Seng Hospital, Lee Kong Chian School of Medicine, SingaporeLi Wei AngNational Centre for Infectious Diseases, SingaporeWilnard Yeong Tze TanNational Centre for Infectious Diseases, SingaporeSiew‐Wai FongDepartment of Biological Sciences, National University of Singapore, SingaporeWoo Chiao TayNational Centre for Infectious Diseases, SingaporeYi‐Hao ChanSingapore Immunology Network, Agency for Science, Technology and Research, SingaporeLaurent RéniaSingapore Immunology Network, Agency for Science, Technology and Research, SingaporeLisa F. P. NgSingapore Immunology Network, Agency for Science, Technology and Research, SingaporeDavid Chien LyeNational Centre for Infectious Diseases, Tan Tock Seng Hospital, Lee Kong Chian School of Medicine, Yong Loo Lin School of Medicine, SingaporeDaniel Ek Kwang ChewDepartment of Endocrinology, Tan Tock Seng Hospital, Lee Kong Chian School of Medicine, SingaporeBarnaby Edward YoungNational Centre for Infectious Diseases, Tan Tock Seng Hospital, Lee Kong Chian School of Medicine, Yong Loo Lin School of Medicine, Singapore
2020en
ABI
Аннотация
Аннотация отсутствует.
Идентификаторы
Цитирования и источники
Цитирований: 2Использованных источников: 0